Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle
Miyatake S, Mizobe Y, Tsoumpra MK, Lim KRQ, Hara Y, Shabanpoor F, Yokota T, Takeda S, Aoki Y. Mol Ther Nucleic Acids. 2019 Mar 1;14:520-535. PubMed
Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates
Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T. Mol Ther. 2019 Jan 2;27(1):76-86. PubMed
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Hu N, Antoury L, Baran TM, Mitra S, Bennett CF, Rigo F, Foster TH, Wheeler TM. Nat Commun. 2018 Dec 7;9(1):5227. PubMed
NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
Watanabe N, Nagata T, Satou Y, Masuda S, Saito T, Kitagawa H, Komaki H, Takagaki K, Takeda S. Mol Ther Nucleic Acids. 2018 Dec 7;13:442-449. PubMed
Cationic Oligospermine-Oligonucleotide Conjugates Provide Carrier-free Splice Switching in Monolayer Cells and Spheroids
Nothisen M, Perche-Létuvée P, Behr JP, Remy JS, Kotera M. Mol Ther Nucleic Acids. 2018 Dec 7;13:483-492. PubMed
Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
Echigoya Y, Lim KRQ, Nakamura A, Yokota T. J Pers Med. 2018 Dec 7;8(4). PubMed
RNA-Mediated Disease Mechanisms in Neurodegenerative Disorders
Neueder A. J Mol Biol. 2018 Dec 29. pii: S0022-2836(18)31287-7. PubMed
Semi-quantitative determination of co-eluting impurities in oligonucleotide drugs using ion-pair reversed-phase liquid chromatography mass spectrometry
Roussis SG, Cedillo I, Rentel C. J Chromatogr A. 2018 Nov 20. pii: S0021-9673(18)31433-X. PubMed
Application of ion pair chromatography coupled with mass spectrometry to assess antisense oligonucleotides concentrations in living cells
Studzińska S, Cywoniuk P, Sobczak K. Analyst. 2018 Nov 21. PubMed
Injectability as a function of viscosity and dosing materials for subcutaneous administration
Watt RP, Khatri H, Dibble ARG. Int J Pharm. 2018 Nov 7;554:376-386. PubMed